GAMSAS: Preventing deaths from infection and tackling antimicrobial resistance
57357’s Efficient Antibiotic Use Saves Lives and Cuts Costs
World Health Organization estimates that Antimicrobial Resistance (AMR) is associated with around 5 million deaths annually.
On June 11th, the British Society for Antimicrobial Chemotherapy (BSAC) concluded that 57357 met the high standards required for Global Recognition in Global Antimicrobial Stewardship Accreditation Scheme “GAMSAS”, marking a significant milestone for the hospital and setting a precedent for healthcare organizations worldwide. Global Recognition in Global Antimicrobial Stewardship Accreditation Scheme (GAMSAS) is the first global accreditation program designed to evaluate and enhance AMS programs in healthcare institutions. It encompasses a comprehensive set of evidence-based strategies, including the development of clinical guidelines, prospective audit and feedback, education and training, infection prevention and control measures, and pharmacodynamic optimization.
As the first hospital in Egypt and the second in the Middle East to be awarded the GAMSAS accreditation. This recognition is a testament to the hospital’s unwavering commitment to enhancing the quality of care and combating antimicrobial resistance (AMR) through effective antimicrobial stewardship (AMS) programs. 57357’s antimicrobial stewardship program (AMS) is measured by specific metrics, ensuring compliance with antimicrobial stewardship program and infectious diseases AMS/ID recommendations, therapeutic drug monitoring (TDM), antibiotic shifting and duration, and consumption metrics.
The hospital’s antimicrobial stewardship program (AMS) represents teamwork, with daily strategy sessions among senior medical professionals, seamless coordination among AMS, laboratory, and infection prevention and control (IPC) teams, and a commitment to continuous education.
Benefits of GAMSAS Accreditation
Accreditation by GAMSAS offers numerous benefits:
Improved Quality of Care: Implementation of best practices in antimicrobial stewardship program AMS leads to more effective treatment of infections and reduced complications associated with inappropriate antibiotic use.
Enhanced Surveillance: Accredited institutions contribute to national and global surveillance programs, informing future antimicrobial stewardship program AMS strategies.
Economic Advantages: GAMSAS helps reduce costs associated with unnecessary antibiotic prescribing and treatment failures due to resistance.
Dissemination of Best Practices: The program fosters the sharing of successful AMS strategies, accelerating the global fight against antimicrobial resistance AMR.
With this accreditation, 57357 joins a global network of healthcare organizations dedicated to maintaining the efficacy of antibiotics and saving patient lives. BSAC is confident that GAMSAS will be a groundbreaking success and looks forward to more hospitals joining the initiative to combat AMR effectively.
For more information about GAMSAS accreditation, please visit: